Form 4 Filing for Actinium Pharmaceuticals, Inc.

This filing details transactions by Jeffrey W. Chell, a director at Actinium Pharmaceuticals, Inc. On September 2, 2026, Chell acquired 61,600 shares of Common Stock as a grant of restricted stock units (RSUs). These RSUs vest in three equal installments over three years. Additionally, Chell was granted 92,400 stock options to purchase Common Stock, with an exercise price of $1.00. These options vest monthly over fifty months, starting from the grant date. The filing indicates that these transactions were direct acquisitions.